Table of contents

Clinical and epidemiological research

• Extended report: Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids (1 November, 2017)

  Jun Won Park, Jeffrey R Curtis, Jinyoung Moon, Yeong Wook Song, Suhnggwon Kim, Eun Bong Lee
• Extended report: Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics (13 December, 2017)

  Thomas Frisell, Eva Baecklund, Karin Bengtsson, Daniela Di Giuseppe, Helena Forsblad-d’Elia, Johan Askling
• Extended report: Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study (26 February, 2018)

  Peter C Taylor, Michael H Schiff, Qingmin Wang, Yusang Jiang, Yanli Zhuang, Regina Kurrasch, Shruti Daga, Ravi Rao, Paul P Tak, Benjamin Hsu
• Extended report: Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis (23 January, 2018)

  Lieve Van Hoovels, Julie Jacobs, Bert Vander Cruyssen, Stefanie Van den Bremt, Patrick Verschueren, Xavier Bossuyt
• Extended report: Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis (15 December, 2017)

  Liana Fraenkel, W Benjamin Nowell, George Michel, Carole Wiedmeyer
• Extended report: Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers (15 December, 2017)

  René Lindholm Cordtz, Samuel Hawley, Daniel Prieto-Alhambra, Pil Højgaard, Kristian Zobbe, Søren Overgaard, Anders Odgaard, Lars Erik Kristensen, Lene Dreyer
• Extended report: Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE) (17 January, 2018)

  Peter Nash, Kamal Ohson, Jessica Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J Gómez-Reino, Jacob A Aelion
• Extended report: Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial (17 January, 2018)

  Désirée van der Heijde, Xenofon Baraliakos, Kay-Geert A Hermann, Robert B M Landewé, Pedro M Machado, Walter P Maksymowych, Owen R Davies, Natasha de Peyrecave, Bengt Hoepken, Lars Bauer, Tommi Nurminen, Juergen Braun
• Extended report:

  Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

  (2 February, 2018)

  Eric F Morand, Teodora Trasieva, Anna Berglind, Gabor G Illei, Raj Tummala
• Extended report: Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis (23 January, 2018)

  Richard M Yeker, Iago Pinal-Fernandez, Takayuki Kishi, Katherine Pak, Ira N Targoff, Frederick W Miller, Lisa G Rider, Andrew L Mammen
• Extended report: Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis (13 December, 2017)

  Rohit Aggarwal, Galina Marder, Diane Carol Koontz, Preeya Nandkumar, Zengbiao Qi, Chester V Oddis
• Extended report: A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease (9 January, 2018) Free

  Florence A Aeschlimann, Ezgi D Batu, Scott W Canna, Ellen Go, Ahmet Gül, Patrycja Hoffmann, Helen L Leavis, Seza Ozen, Daniella M Schwartz, Deborah L Stone, Annet van Royen-Kerkof, Daniel L Kastner, Ivona Aksentijevich, Ronald M Laxer